{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:32:20Z","timestamp":1783042340698,"version":"3.54.6"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11030-023-10779-4","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T22:02:13Z","timestamp":1705874533000},"page":"3817-3833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anticancer activity features of imidazole-based ionic liquids and lysosomotropic detergents: in silico and in vitro studies"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-0478","authenticated-orcid":false,"given":"Anastasiia","family":"Gryniukova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-5233","authenticated-orcid":false,"given":"Petro","family":"Borysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Myziuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-1181","authenticated-orcid":false,"given":"Diana","family":"Alieksieieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6161-9833","authenticated-orcid":false,"given":"Diana","family":"Hodyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8464-3692","authenticated-orcid":false,"given":"Ivan","family":"Semenyuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-7332","authenticated-orcid":false,"given":"Vasyl","family":"Kovalishyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-6076","authenticated-orcid":false,"given":"Larysa","family":"Metelytsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5200-5247","authenticated-orcid":false,"given":"Sergiy","family":"Rogalsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-651X","authenticated-orcid":false,"given":"Sergey","family":"Tcherniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"10779_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149:778\u2013789. https:\/\/doi.org\/10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"key":"10779_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"M Naghavi","year":"2017","unstructured":"Naghavi M, Abajobir AA, Abbafati C et al (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet 390:1151\u20131210. https:\/\/doi.org\/10.1016\/S0140-6736(17)32152-9","journal-title":"Lancet"},{"key":"10779_CR3","first-page":"2999","volume":"32","author":"R Ali","year":"2012","unstructured":"Ali R, Mirza Z, Ashraf GMD, Kamal MA, Ansari SA, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Sheikh IA (2012) New anticancer agents: recent developments in tumor therapy. Anticancer Res 32:2999\u20133005","journal-title":"Anticancer Res"},{"key":"10779_CR4","unstructured":"Amjad MT, Chidharla A, Kasi A (2023) Cancer Chemotherapy. StatPearls Publishing, Treasure Island. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564367. Accessed 27 Feb 2023"},{"key":"10779_CR5","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R (2020) Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 21:3233. https:\/\/doi.org\/10.3390\/ijms21093233","journal-title":"Int J Mol Sci"},{"key":"10779_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1039\/B921805J","volume":"12","author":"J \u0141uczak","year":"2010","unstructured":"\u0141uczak J, Jungnickel C, \u0141acka I, Stolte S, Hupka J (2010) Antimicrobial and surface activity of 1-alkyl-3-methylimidazolium derivatives. Green Chem 12:593\u2013601. https:\/\/doi.org\/10.1039\/B921805J","journal-title":"Green Chem"},{"key":"10779_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jcis.2010.11.063","volume":"355","author":"A Cornellas","year":"2011","unstructured":"Cornellas A, Perez L, Comelles F, Ribosa I, Manresa A (2011) Self-aggregation and antimicrobial activity of imidazolium and pyridinium based ionic liquids in water solutions. J Colloid Interface Sci 355:164\u2013171. https:\/\/doi.org\/10.1016\/j.jcis.2010.11.063","journal-title":"J Colloid Interface Sci"},{"key":"10779_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cbdd.12770","volume":"88","author":"D Hodyna","year":"2016","unstructured":"Hodyna D, Kovalishyn V, Rogalsky S, Blagodatnyi V, Petko K, Metelytsia L (2016) Antibacterial activity of imidazolium-based ionic liquids investigated by QSAR modelling and experimental studies. Chem Biol Drug Des 88:422\u2013433. https:\/\/doi.org\/10.1111\/cbdd.12770","journal-title":"Chem Biol Drug Des"},{"key":"10779_CR9","doi-asserted-by":"publisher","first-page":"109907","DOI":"10.1016\/j.msec.2019.109907","volume":"104","author":"V Florio","year":"2019","unstructured":"Florio V, Becherini S, D\u2019Andrea F, Lupetti A, Chiappe C, Guazzelli L (2019) Comparative evaluation of antimicrobial activity of different types of ionic liquids. Mater Sci Eng C 104:109907. https:\/\/doi.org\/10.1016\/j.msec.2019.109907","journal-title":"Mater Sci Eng C"},{"key":"10779_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/ijms22020563","volume":"22","author":"I Semenyuta","year":"2021","unstructured":"Semenyuta I, Trush M, Kovalishyn V, Rogalsky S, Hodyna D, Karpov P, Xia Z, Tetko I, Metelytsia L (2021) Structure-activity relationship modeling and experimental validation of the imidazolium and pyridinium based ionic liquids as potential antibacterials of MDR Acinetobacter baumannii and Staphylococcus aureus. Int J Mol Sci 22:563. https:\/\/doi.org\/10.3390\/ijms22020563","journal-title":"Int J Mol Sci"},{"key":"10779_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1039\/C3MD00222E","volume":"4","author":"HS Schrekker","year":"2013","unstructured":"Schrekker HS, Donato RK, Fuentefria AM, Bergamo V, Oliveira LF, Machado MM (2013) Imidazolium salts as antifungal agents: activity against emerging yeast pathogens, without human leucocyte toxicity. Med Chem Commun 4:1457\u20131460. https:\/\/doi.org\/10.1039\/C3MD00222E","journal-title":"Med Chem Commun"},{"key":"10779_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/lam.12338","volume":"60","author":"VZ Bergamo","year":"2014","unstructured":"Bergamo VZ, Donato RK, Dalla Lana DF, Donato KJZ, Ortega GG, Schrekker HS, Fuentefria AM (2014) Imidazolium salts as antifungal agents: strong antibiofilm activity against multidrug-resistant Candida tropicalis isolates. Lett Appl Microbiol 60:66\u201371. https:\/\/doi.org\/10.1111\/lam.12338","journal-title":"Lett Appl Microbiol"},{"key":"10779_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2174\/1573407215666191007120402","volume":"16","author":"L Metelytsia","year":"2020","unstructured":"Metelytsia L, Trush M, Semenyuta I, Rogalsky S, Kobzar O, Kalashnikova L, Blagodatnyi V, Hodyna D (2020) Ionic liquids with anti-candida and anticancer dual activity as N-myristoyltransferase inhibitors. Curr Bioact Compd 16:1036\u20131041. https:\/\/doi.org\/10.2174\/1573407215666191007120402","journal-title":"Curr Bioact Compd"},{"key":"10779_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1039\/B821842K","volume":"11","author":"L Carson","year":"2009","unstructured":"Carson L, Chau PKW, Earle MJ, Gilea MA, Gilmore BF, Gorman SP, McCann MT, Seddon KR (2009) Antibiofilm activities of 1-alkyl-3-methylimidazolium chloride ionic liquids. Creen Chem 11:492\u2013497. https:\/\/doi.org\/10.1039\/B821842K","journal-title":"Creen Chem"},{"key":"10779_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.colsurfb.2017.04.040","volume":"155","author":"GKK Reddy","year":"2017","unstructured":"Reddy GKK, Nancharaiah YV, Venugopalan VP (2017) Long alkyl-chain imidazolium ionic liquids: antibiofilm activity against phototrophic biofilms. Colloids Surf B: Biointerfaces 155:487\u2013496. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.04.040","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10779_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cmdc.201600480","volume":"12","author":"AR Dias","year":"2017","unstructured":"Dias AR, Costa-Rodrigues J, Helena-Fernandes M, Ferraz R, Prud\u00eancio C (2017) Anticancer potential of ionic liquids. ChemMedChem 12:11\u201318. https:\/\/doi.org\/10.1002\/cmdc.201600480","journal-title":"ChemMedChem"},{"key":"10779_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1021\/bk-2010-1038.ch008","volume":"1038","author":"V Kumar","year":"2010","unstructured":"Kumar V, Malhotra SV (2010) Antitumor activity of ionic liquids on human tumor cell lines. ACS Symp Ser 1038:91\u2013102. https:\/\/doi.org\/10.1021\/bk-2010-1038.ch008","journal-title":"ACS Symp Ser"},{"key":"10779_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bmcl.2009.11.085","volume":"20","author":"SV Malhotra","year":"2010","unstructured":"Malhotra SV, Kumar V (2010) A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids. Bioorg Med Chem Lett 20:581\u2013585. https:\/\/doi.org\/10.1016\/j.bmcl.2009.11.085","journal-title":"Bioorg Med Chem Lett"},{"key":"10779_CR19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1039\/B704503D","volume":"9","author":"X Wang","year":"2007","unstructured":"Wang X, Ohlin CA, Lu Q, Fei Z, Hu J, Dyson PJ (2007) Cytotoxicity of ionic liquids and precursor compounds towards human cell line HeLa. Green Chem 9:1191\u20131197. https:\/\/doi.org\/10.1039\/B704503D","journal-title":"Green Chem"},{"key":"10779_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1039\/B718860A","volume":"10","author":"A Garc\u00eda-Lorenzo","year":"2008","unstructured":"Garc\u00eda-Lorenzo A, Tojo E, Tojo J, Teijeira M, Rodr\u00edguez-Berrocal FJ, P\u00e9rez-Gonz\u00e1les M, Mart\u00ednez-Zorzano VS (2008) Cytotoxicity of selected imidazolium-derived ionic liquids in the human Caco-2 cell line. Sub-structural toxicological interpretation through a QSAR study. Green Chem 10:508\u2013516. https:\/\/doi.org\/10.1039\/B718860A","journal-title":"Green Chem"},{"key":"10779_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/tox.20443","volume":"24","author":"RA Kumar","year":"2009","unstructured":"Kumar RA, Papa\u00efconomou N, Lee JM, Salminen J, Clark DS, Prausnitz JM (2009) In vitro cytotoxicities of ionic liquids: effect of cation rings, functional groups, and anions. Environ Toxicol 24:388\u2013395. https:\/\/doi.org\/10.1002\/tox.20443","journal-title":"Environ Toxicol"},{"key":"10779_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.18388\/abp.2000_3984","volume":"47","author":"S Przestalski","year":"2000","unstructured":"Przestalski S, Sarapuk J, Kleszczy\u0144ska H, Gabrielska J, H\u0142adyszowski J, Trela Z, Kuczera J (2000) Influence of amphiphilic compounds on membranes. Acta Biochim Pol 47:627\u2013638","journal-title":"Acta Biochim Pol"},{"key":"10779_CR23","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1039\/B711119C","volume":"9","author":"S Stolte","year":"2007","unstructured":"Stolte S, Arning J, Bottin-Weber U, M\u00fcller A, Pitner W-R, Welz-Biermann U, Jastorff B, Ranke J (2007) Effects of different head groups and functionalised side chains on the cytotoxicity of ionic liquids. Green Chem 9:760\u2013767. https:\/\/doi.org\/10.1039\/B711119C","journal-title":"Green Chem"},{"key":"10779_CR24","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1007\/s11356-018-3924-8","volume":"26","author":"M Trush","year":"2019","unstructured":"Trush M, Metelytsia L, Semenyuta I, Kalashnikova L, Papeykin O, Venger I, Tarasyuk O, Bodachivska L, Blagodatnyi V, Rogalsky S (2019) Reduced ecotoxicity and improved biodegradability of cationic biocides based on ester-functionalized pyridinium ionic liquids. Environ Sci Poll Res 26:4878\u20134889. https:\/\/doi.org\/10.1007\/s11356-018-3924-8","journal-title":"Environ Sci Poll Res"},{"key":"10779_CR25","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/S0960-894X(03)00591-2","volume":"13","author":"S Khabnadideh","year":"2003","unstructured":"Khabnadideh S, Rezaei Z, Khalafi-Nezhad A, Bahrinajafi R, Mohamadi R, Farrokhroz AA (2003) Synthesis of N-alkylated derivatives of imidazole as antibacterial agents. Bioorg Med Chem Lett 13:2863\u20132865. https:\/\/doi.org\/10.1016\/S0960-894X(03)00591-2","journal-title":"Bioorg Med Chem Lett"},{"key":"10779_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/aac.15.4.603","volume":"15","author":"MJ Henry","year":"1979","unstructured":"Henry MJ, Sisler HD (1979) Effects of miconazole and dodecylimidazole on sterol biosynthesis in Ustilago maydis. Antimicrob Agents Chemoter 15:603\u2013607. https:\/\/doi.org\/10.1128\/aac.15.4.603","journal-title":"Antimicrob Agents Chemoter"},{"key":"10779_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0165-1218(87)90034-6","volume":"189","author":"MO Bradley","year":"1987","unstructured":"Bradley MO, Taylor VI, Armstrong MJ, Galloway SM (1987) Relationships among cytotoxicity, lysosomal breakdown, chromosome aberrations, and DNA double-strand breaks. Mutat Res 189:69\u201379. https:\/\/doi.org\/10.1016\/0165-1218(87)90034-6","journal-title":"Mutat Res"},{"key":"10779_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/bjc.1993.13","volume":"67","author":"MJ Boyer","year":"1993","unstructured":"Boyer MJ, Horn I, Firestone RA, Steele-Norwood D, Tannock IF (1993) pH dependent cytotoxicity of N-dodecylimidazole: a compound that acquires detergent properties under acidic conditions. Br J Cancer 67:81\u201387. https:\/\/doi.org\/10.1038\/bjc.1993.13","journal-title":"Br J Cancer"},{"key":"10779_CR29","first-page":"507","volume":"49","author":"PD Wilson","year":"1989","unstructured":"Wilson PD, Hreniuk D, Lenard J (1989) Reduced cytotoxicity of the lysosomotropic detergent N-dodecylimidazole after differentiation of HL60 promyelocytes. Cancer Res 49:507\u2013510","journal-title":"Cancer Res"},{"key":"10779_CR30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0960-894X(95)00136-H","volume":"5","author":"GM Dubowchik","year":"1995","unstructured":"Dubowchik GM, Gawlak SL, Firestone RA (1995) The in vitro effects of three lysosomotropic detergents against three human tumor cell lines. Bioorg Med Chem Lett 5:893\u2013898. https:\/\/doi.org\/10.1016\/0960-894X(95)00136-H","journal-title":"Bioorg Med Chem Lett"},{"key":"10779_CR31","doi-asserted-by":"publisher","first-page":"22182","DOI":"10.1039\/C8RA02095G","volume":"8","author":"G Hao","year":"2018","unstructured":"Hao G, Xu ZP, Li L (2018) Manipulating extracellular tumour pH: an effective target for cancer therapy. RSC Adv 8:22182\u201322192. https:\/\/doi.org\/10.1039\/C8RA02095G","journal-title":"RSC Adv"},{"key":"10779_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0005-2736(03)00049-X","volume":"1611","author":"F-J Chen","year":"2003","unstructured":"Chen F-J, Asokan A, Cho MJ (2003) Cytosolic delivery of macromolecules: I. Synthesis and characterization of pH-sensitive acyloxyalkylimidazoles. Biochim Biophys Acta 1611:140\u2013150. https:\/\/doi.org\/10.1016\/S0005-2736(03)00049-X","journal-title":"Biochim Biophys Acta"},{"key":"10779_CR33","doi-asserted-by":"publisher","first-page":"e22739","DOI":"10.1371\/journal.pone.0022739","volume":"6","author":"M Cea","year":"2011","unstructured":"Cea M, Soncini D, Fruscione F, Raffaghello L, Garuti A, Emionite L, Moran E, Magnone M, Zoppoli G, Reverberi D, Caffa I, Salis A, Cagnetta A, Bergamaschi M, Casciaro S, Pierri I, Damonte G, Ansaldi F, Gobbi M, Pistoia V, Ballestrero A, Patrone F, Bruzzone S, Nencioni A (2011) Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. PLoS ONE 6:e22739. https:\/\/doi.org\/10.1371\/journal.pone.0022739","journal-title":"PLoS ONE"},{"key":"10779_CR34","unstructured":"Otto M (2018) In vitro study of in silico designed sirtuin 1 and bromodomain 4 inhibitors on human neuroblastoma SH-SY5Y and acute myeloid leukemia U937 cells. Dissertation, University of Pretoria"},{"key":"10779_CR35","doi-asserted-by":"publisher","first-page":"21272","DOI":"10.1038\/s41598-020-78024-8","volume":"10","author":"CA Moreira-Nunes","year":"2020","unstructured":"Moreira-Nunes CA, Mesquita FP, de Sousa Portilho AJ, Mello FAR Jr, da Silva Mau\u00e9s JH, da Costa Pantoja L, Wanderley AV, Khayat AS, Zuercher WJ, Montenegro RC, de Moraes-Filho MO, de Moraes MEA (2020) Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia. Sci Rep 10:21272. https:\/\/doi.org\/10.1038\/s41598-020-78024-8","journal-title":"Sci Rep"},{"key":"10779_CR36","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3324\/haematol.2021.278692","volume":"106","author":"J Leonard","year":"2021","unstructured":"Leonard J, Wolf JS, Degnin M, Eide CA, LaTocha D, Lenz K, Wilmot B, Mullighan CG, Loh M, Hunger SP, Druker BJ, Loriaux MM, Tyner JW, Chang BH (2021) Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia. Haematologica 106:2990\u20132994. https:\/\/doi.org\/10.3324\/haematol.2021.278692","journal-title":"Haematologica"},{"key":"10779_CR37","doi-asserted-by":"publisher","first-page":"e108758","DOI":"10.1371\/journal.pone.0108758","volume":"9","author":"M Michaelis","year":"2014","unstructured":"Michaelis M, Selt F, Rothweiler F, L\u00f6schmann N, N\u00fcsse B, Dirks WG, Zehner R, Cinatl JJ (2014) Aurora kinases as targets in drug-resistant neuroblastoma cells. PLoS ONE 9:e108758. https:\/\/doi.org\/10.1371\/journal.pone.0108758","journal-title":"PLoS ONE"},{"key":"10779_CR38","doi-asserted-by":"publisher","first-page":"115033","DOI":"10.1016\/j.ejmech.2022.115033","volume":"247","author":"M Rishfi","year":"2023","unstructured":"Rishfi M, Krols S, Martens F, Bekaert SL, Sanders E, Eggermont A, De Vloed F, Goulding JR, Risseeuw M, Molenaar J, De Wilde B, Van Calenbergh S, Durinck K (2023) Targeted AURKA degradation: towards new therapeutic agents for neuroblastoma. Eur J Med Chem 247:115033. https:\/\/doi.org\/10.1016\/j.ejmech.2022.115033","journal-title":"Eur J Med Chem"},{"key":"10779_CR39","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1158\/1535-7163.MCT-21-0126","volume":"20","author":"TJ O\u2019Donohue","year":"2021","unstructured":"O\u2019Donohue TJ, Ib\u00e1\u00f1ez G, Coutinho DF, Mauguen A, Siddiquee A, Rosales N, Calder P, Ndengu A, You D, Long M, Roberts SS, Kung AL, Dela Cruz FS (2021) Translational strategies for repotrectinib in neuroblastoma. Mol Cancer Ther 20:2189\u20132197. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0126","journal-title":"Mol Cancer Ther"},{"key":"10779_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1517\/14728222.2012.662956","volume":"3","author":"MM Reddy","year":"2012","unstructured":"Reddy MM, Deshpande A, Sattler M (2012) Targeting JAK2 in the therapy of myeloproliferative neoplasms. Expert Opin Ther Targets 3:313\u2013324. https:\/\/doi.org\/10.1517\/14728222.2012.662956","journal-title":"Expert Opin Ther Targets"},{"key":"10779_CR41","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1158\/0008-5472.CAN-18-2759","volume":"79","author":"O Yogev","year":"2019","unstructured":"Yogev O, Almeida GS, Barker KT, George SL, Kwok C, Campbell J, Zarowiecki M, Kleftogiannis D, Smith LM, Hallsworth A, Berry P, M\u00f6cklinghoff T, Webber HT, Danielson LS, Buttery B, Calton EA, da Costa BM, Poon E, Jamin Y, Lise S, Veal GJ, Sebire N, Robinson SP, Anderson J, Chesler L (2019) In vivo modeling of chemoresistant neuroblastoma provides new insights into chemorefractory disease and metastasis. Cancer Res 79:5382\u20135393. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2759","journal-title":"Cancer Res"},{"key":"10779_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.31857\/S0026898420020111","volume":"54","author":"TD Lebedev","year":"2020","unstructured":"Lebedev TD, Vagapova ER, Astashkova OO, Spirin PV, Prassolov VS (2020) Inhibition of non-receptor tyrosine kinase JAK2 reduces neuroblastoma cell growth and enhances the action of doxorubicin. Mol Biol (Mosk) 54:293\u2013299. https:\/\/doi.org\/10.31857\/S0026898420020111","journal-title":"Mol Biol (Mosk)"},{"key":"10779_CR43","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/jm301431y","volume":"56","author":"X Zhao","year":"2013","unstructured":"Zhao X, Allison D, Condon B, Zhang F, Gheyi T, Zhang A, Ashok S, Russell M, MacEwan I, Qian Y, Jamison JA, Luz JG (2013) The 2.5 \u00c5 crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition. J Med Chem 56:963\u2013969. https:\/\/doi.org\/10.1021\/jm301431y","journal-title":"J Med Chem"},{"key":"10779_CR44","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1021\/acs.chemrev.7b00246","volume":"117:10","author":"Z Lei","year":"2017","unstructured":"Lei Z, Chen B, Koo YM, MacFarlane DR (2017) Introduction: ionic liquids. Chem Rev 117:10:6633\u20136635. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00246","journal-title":"Chem Rev"},{"key":"10779_CR45","doi-asserted-by":"publisher","first-page":"7132","DOI":"10.1021\/acs.chemrev.6b00562","volume":"117","author":"KS Egorova","year":"2017","unstructured":"Egorova KS, Gordeev EG, Ananikov VP (2017) Biological activity of ionic liquids and their application in pharmaceutics and medicine. Chem Rev 117:7132\u20137189. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00562","journal-title":"Chem Rev"},{"key":"10779_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/cssc.201300459","volume":"7","author":"KS Egorova","year":"2014","unstructured":"Egorova KS, Ananikov VP (2014) Toxicity of ionic liquids: eco(cyto)activity as complicated, but unavoidable parameter for task-specific optimization. Chemsuschem 7:336\u2013360. https:\/\/doi.org\/10.1002\/cssc.201300459","journal-title":"Chemsuschem"},{"key":"10779_CR47","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/onc.2014.269","volume":"34","author":"K Althoff","year":"2015","unstructured":"Althoff K, Beckers A, Bell E, Nortmeyer M, Thor T, Spr\u00fcssel A, Lindner S, De Preter K, Florin A, Heukamp LC, Klein-Hitpass L, Astrahantseff K, Kumps C, Speleman F, Eggert A, Westermann F, Schramm A, Schulte JH (2015) A cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene 34:3357\u20133368. https:\/\/doi.org\/10.1038\/onc.2014.269","journal-title":"Oncogene"},{"key":"10779_CR48","doi-asserted-by":"publisher","first-page":"e1002135","DOI":"10.1371\/journal.pgen.1002135","volume":"7","author":"GM Marshall","year":"2011","unstructured":"Marshall GM, Liu PY, Gherardi S, Scarlett CJ, Bedalov A, Xu N, Iraci N, Valli E, Ling D, Thomas W, van Bekkum M, Sekyere E, Jankowski K, Trahair T, Mackenzie KL, Haber M, Norris MD, Biankin AV, Perini G, Liu T (2011) SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet 7:e1002135. https:\/\/doi.org\/10.1371\/journal.pgen.1002135","journal-title":"PLoS Genet"},{"key":"10779_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13046-019-1066-6","volume":"38","author":"V Mlakar","year":"2019","unstructured":"Mlakar V, Jurkovic Mlakar S, Lesne L, Marino D, Rathi KS, Maris JM, Ansari M, Gumy-Pause F (2019) PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level. J Exp Clin Cancer Res 38:69. https:\/\/doi.org\/10.1186\/s13046-019-1066-6","journal-title":"J Exp Clin Cancer Res"},{"key":"10779_CR50","doi-asserted-by":"publisher","first-page":"e3126","DOI":"10.1038\/cddis.2017.526","volume":"8","author":"L Liu","year":"2017","unstructured":"Liu L, Xu F, Chang CK, He Q, Wu LY, Zhang Z, Li X (2017) MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21. Cell Death Dis 8:e3126. https:\/\/doi.org\/10.1038\/cddis.2017.526","journal-title":"Cell Death Dis"},{"key":"10779_CR51","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-d","volume":"17","author":"JC Law","year":"1993","unstructured":"Law JC, Ritke MK, Yalowich JC, Leder GH, Ferrell RE (1993) Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line. Leuk Res 17:1045\u20131050. https:\/\/doi.org\/10.1016\/0145-2126(93)90161-d","journal-title":"Leuk Res"},{"key":"10779_CR52","doi-asserted-by":"publisher","first-page":"100589","DOI":"10.1016\/j.curtheres.2020.100589","volume":"92","author":"M Houssein","year":"2020","unstructured":"Houssein M, Abi Saab W, Khalil M, Khalife H, Fatfat M (2020) Cell death by gallotannin is associated with inhibition of the JAK\/STAT pathway in human colon cancer cells. Curr Ther Res Clin Exp 92:100589. https:\/\/doi.org\/10.1016\/j.curtheres.2020.100589","journal-title":"Curr Ther Res Clin Exp"},{"key":"10779_CR53","doi-asserted-by":"publisher","first-page":"896426","DOI":"10.3389\/fonc.2022.896426","volume":"12","author":"J Niu","year":"2022","unstructured":"Niu J, Peng D, Liu L (2022) Drug resistance mechanisms of acute myeloid leukemia stem cells. Front Oncol 12:896426. https:\/\/doi.org\/10.3389\/fonc.2022.896426","journal-title":"Front Oncol"},{"key":"10779_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","volume":"17","author":"B Donati","year":"2018","unstructured":"Donati B, Lorenzini E, Ciarrocchi A (2018) BRD4 and cancer: going beyond transcriptional regulation. Mol Cancer 17:164. https:\/\/doi.org\/10.1186\/s12943-018-0915-9","journal-title":"Mol Cancer"},{"key":"10779_CR55","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fphar.2020.01043","volume":"11","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Li X, Liu Z, Huang L, Yao Y, Li L, Chen J, Zhang R, Zhou J, Wang L, Zhang QQ (2020) A bromodomain-containing protein 4 (BRD4) inhibitor suppresses angiogenesis by regulating AP-1 expression. Front Pharmacol 11:1043. https:\/\/doi.org\/10.3389\/fphar.2020.01043","journal-title":"Front Pharmacol"},{"key":"10779_CR56","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1039\/c8md00198g","volume":"9","author":"Y Duan","year":"2018","unstructured":"Duan Y, Guan Y, Qin W, Zhai X, Yu B, Liu H (2018) Targeting Brd4 for cancer therapy: inhibitors and degraders. Medchemcomm 9:1779\u20131802. https:\/\/doi.org\/10.1039\/c8md00198g","journal-title":"Medchemcomm"},{"key":"10779_CR57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","volume":"25","author":"I Sushko","year":"2011","unstructured":"Sushko I, Novotarskyi S, Korner R, Pandey AK, Rupp M, Teetz W, Brandmaier S, Abdelaziz A, Prokopenko VV, Tanchuk VY, Todeschini R, Varnek A, Marcou G, Ertl P, Potemkin V, Grishina M, Gasteiger J, Schwab C, Baskin II, Palyulin VA, Radchenko EV, Welsh WJ, Kholodovych V, Chekmarev D, Cherkasov A, Aires-de-Sousa J, Zhang QY, Bender A, Nigsch F, Patiny L, Williams A, Tkachenko V, Tetko IV (2011) Online chemical modelling environment (OCHEM): web platform. J Comput Aided Mol Des 25:533\u2013554. https:\/\/doi.org\/10.1007\/s10822-011-9440-2","journal-title":"J Comput Aided Mol Des"},{"key":"10779_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13321-020-00423-w","volume":"12","author":"P Karpov","year":"2020","unstructured":"Karpov P, Godin G, Tetko IV (2020) Transformer-CNN: Swiss knife for QSAR modeling and interpretation. J Cheminform 12:17. https:\/\/doi.org\/10.1186\/s13321-020-00423-w","journal-title":"J Cheminform"},{"key":"10779_CR59","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","volume":"59","author":"K Yang","year":"2019","unstructured":"Yang K, Swanson K, Jin W, Coley C, Eiden P, Gao H, Guzman-Perez A, Hopper T, Kelley B, Mathea M, Palmer A, Settels V, Jaakkola T, Jensen K, Barzilay R (2019) Analyzing learned molecular representations for property prediction. J Chem Inf Model 59:3370\u20133388. https:\/\/doi.org\/10.1021\/acs.jcim.9b00237","journal-title":"J Chem Inf Model"},{"key":"10779_CR60","doi-asserted-by":"publisher","first-page":"831835","DOI":"10.1007\/978-3-030-30493-5_79","volume-title":"Artificial neural networks and machine learning\u2014ICANN 2019: workshop and special sessions, ICANN 2019","author":"IV Tetko","year":"2019","unstructured":"Tetko IV, Karpov P, Bruno E, Kimber TB, Godin G (2019) Augmentation is what you need! In: Tetko I, K\u016frkov\u00e1 V, Karpov P, Theis F (eds) Artificial neural networks and machine learning\u2014ICANN 2019: workshop and special sessions, ICANN 2019, vol 11731. Springer, Cham, p 831835. https:\/\/doi.org\/10.1007\/978-3-030-30493-5_79"},{"key":"10779_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L (2001) Random forests. Mach Learn 45:5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324","journal-title":"Mach Learn"},{"key":"10779_CR62","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1021\/acs.jcim.9b00526","volume":"59","author":"AV Zakharov","year":"2019","unstructured":"Zakharov AV, Zhao T, Nguyen DT, Peryea T, Sheils T, Yasgar A, Huang R, Southall N, Simeonov A (2019) Novel consensus architecture to improve performance of large-scale multitask deep learning QSAR models. J Chem Inf Model 59:4613\u20134624. https:\/\/doi.org\/10.1021\/acs.jcim.9b00526","journal-title":"J Chem Inf Model"},{"key":"10779_CR63","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1021\/ci800151m","volume":"48","author":"IV Tetko","year":"2008","unstructured":"Tetko IV, Sushko I, Pandey AK, Zhu H, Tropsha A, Papa E, Oberg T, Todeschini R, Fourches D, Varnek A (2008) Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. J Chem Inf Model 48:1733\u20131746. https:\/\/doi.org\/10.1021\/ci800151m","journal-title":"J Chem Inf Model"},{"key":"10779_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cem.1296","volume":"24","author":"Y Sushko","year":"2010","unstructured":"Sushko Y, Novotarskyi S, K\u00f6rner R, Pandey AK, Kovalishyn VV, Prokopenko VV, Tetko IV (2010) Applicability domain for in silico models to achieve accuracy of experimental measurements. J Chemom 24:202\u2013208. https:\/\/doi.org\/10.1002\/cem.1296","journal-title":"J Chemom"},{"key":"10779_CR65","unstructured":"https:\/\/www.rcsb.org\/structure\/4PS3"},{"key":"10779_CR66","unstructured":"https:\/\/www.rcsb.org\/structure\/2GL7"},{"key":"10779_CR67","unstructured":"https:\/\/www.rcsb.org\/structure\/3LBL"},{"key":"10779_CR68","unstructured":"https:\/\/www.rcsb.org\/structure\/4JOA"},{"key":"10779_CR69","unstructured":"https:\/\/www.rcsb.org\/structure\/5CT7"},{"key":"10779_CR70","unstructured":"https:\/\/www.rcsb.org\/structure\/6DKB"},{"key":"10779_CR71","unstructured":"https:\/\/www.rcsb.org\/structure\/4AT4"},{"key":"10779_CR72","unstructured":"https:\/\/www.rcsb.org\/structure\/5WUU"},{"key":"10779_CR73","unstructured":"https:\/\/www.rcsb.org\/structure\/3UIH"},{"key":"10779_CR74","unstructured":"https:\/\/www.rcsb.org\/structure\/4I5I"},{"key":"10779_CR75","unstructured":"https:\/\/www.rcsb.org\/structure\/3VO3"},{"key":"10779_CR76","unstructured":"https:\/\/www.rcsb.org\/structure\/4EZ5"},{"key":"10779_CR77","unstructured":"https:\/\/www.rcsb.org\/structure\/2W96"},{"key":"10779_CR78","unstructured":"https:\/\/www.rcsb.org\/structure\/4B0G"},{"key":"10779_CR79","unstructured":"https:\/\/www.rcsb.org\/structure\/2BFX"},{"key":"10779_CR80","unstructured":"https:\/\/www.rcsb.org\/structure\/1IEP"},{"key":"10779_CR81","unstructured":"https:\/\/www.rcsb.org\/structure\/1Y1U"},{"key":"10779_CR82","unstructured":"https:\/\/www.rcsb.org\/structure\/4HYS"},{"key":"10779_CR83","unstructured":"https:\/\/www.rcsb.org\/structure\/1OJD"},{"key":"10779_CR84","unstructured":"https:\/\/www.rcsb.org\/structure\/4EHZ"},{"key":"10779_CR85","unstructured":"https:\/\/www.rcsb.org\/structure\/6VNE"},{"key":"10779_CR86","unstructured":"https:\/\/www.rcsb.org\/structure\/6E6E"},{"key":"10779_CR87","volume-title":"Discovery Studio Visualizer","author":"Dassault Syst\u00e8mes BIOVIA","year":"2021","unstructured":"Dassault Syst\u00e8mes BIOVIA (2021) Discovery Studio Visualizer. Dassault Syst\u00e8mes, San Diego"},{"key":"10779_CR88","first-page":"57","volume":"17","author":"MF Sanner","year":"1999","unstructured":"Sanner MF (1999) Python: a programming language for software integration and development. J Mol Graph Model 17:57\u201361","journal-title":"J Mol Graph Model"},{"key":"10779_CR89","unstructured":"Marvin Sketch 5.3.735 (2017) ChemAxon. Available from: http:\/\/www.chemaxon.com"},{"key":"10779_CR90","unstructured":"MOPAC2016, James J. P. Stewart, (2016) Stewart Computational Chemistry, Springs, http:\/\/OpenMOPAC.net"},{"key":"10779_CR91","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"10779_CR92","unstructured":"Discovery Studio Visualizer, https:\/\/discover.3ds.com\/. Accessed on 15 July, 2023"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10779-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:05:44Z","timestamp":1734609944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10779-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10779"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10779-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3580578\/v1","asserted-by":"object"}]},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}